Cannabidiol modulates brain molecular alterations, gut microbiota dysbiosis, and alcohol self-administration in a mouse model of fetal alcohol spectrum disorder. Cannabidiol (CBD) could become a ...
Alcohol-associated liver disease (ALD) remains a leading cause of cirrhosis and liver-related mortality worldwide, with few effective therapies. In alcohol-associated hepatitis (AH), hepatocytes ...
Cannabidiol (CBD) could become a therapeutic tool to address some of the most frequent and disabling consequences of fetal alcohol spectrum disorder (FASD), a condition caused by alcohol exposure ...